Lung Cancer Screening and Prevention Act of 2025
- Last Action
- 2/18/2025
Actions
- 2025-02-18Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-18Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-18Introduced in House
- 2025-02-18Introduced in House
CRS Summary
As of 2025-02-18 (00)
Lung Cancer Screening and Prevention Act of 2025
This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the Food and Drug Administration, regardless of whether they are recommended by the United States Preventive Services Task Force. The Centers for Medicare & Medicaid Services must set coverage and payment limits for such tests. (Currently, Medicare covers screening tests for the early detection of lung cancer if they are recommended by the task force.)
Cosponsors (9)
- Timothy Kennedy (D-NY)
- H. Griffith (R-VA)
- Darin LaHood (R-IL)
- Darren Soto (D-FL)
- Debbie Wasserman Schultz (D-FL)
- Robert Bresnahan (R-PA)
- Joe Neguse (D-CO)
- Paul Tonko (D-NY)
- Ted Lieu (D-CA)
Subjects
- Cancer
- Cardiovascular and respiratory health
- Health care coverage and access
- Health promotion and preventive care
- Medical tests and diagnostic methods
- Medicare
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.